D68.5 is a non-billable/non-specific diagnosis code from the 2025 ICD-10-CM used to classify the following condition: Primary thrombophilia.
Inclusion term
Primary hypercoagulable states
Type 1 excludes
Antiphospholipid syndrome (D68.61)
Lupus anticoagulant (D68.62)
Secondary activated protein C resistance (D68.69)
Secondary antiphospholipid antibody syndrome (D68.69)
Secondary lupus anticoagulant with hypercoagulable state (D68.69)
Secondary systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.69)
Systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)
Systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder (D68.312)
Thrombotic thrombocytopenic purpura (M31.19)
Codes
Versions
2025
No changes
2024
No changes
2023
No changes
2022
Code changed
Type 1 excludes
antiphospholipid syndrome (D68.61)lupus anticoagulant (D68.62)secondary activated protein C resistance (D68.69)secondary antiphospholipid antibody syndrome (D68.69)secondary lupus anticoagulant with hypercoagulable state (D68.69)secondary systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.69)systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder (D68.312)thrombotic thrombocytopenic purpura (M31.1)
- antiphospholipid syndrome (D68.61)
- lupus anticoagulant (D68.62)
- secondary activated protein C resistance (D68.69)
- secondary antiphospholipid antibody syndrome (D68.69)
- secondary lupus anticoagulant with hypercoagulable state (D68.69)
- secondary systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.69)
- systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)
- systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder (D68.312)
- thrombotic thrombocytopenic purpura (M31.19)
2021
No changes
2020
No changes
2019
No changes
2018
No changes
2017
No changes
2016
New code